cAMP accumulation assay Wild-type GLP-1R and GLP-1R mutants were cloned into the expression receptor pcDNA3.1/V5-His-TOPO vector (Invitrogen) at the HindIII and EcoRI sites by using the QuickChange site-directed mutagenesis and a flag-tag was inserted after native signal sequence (see primers in Supplementary Table 2)
Weight loss was consistent and progressive, starting at 3.93% at three months and reaching 7.87% at twelve months. In addition, several case series studies have demonstrated benefits of GLP-1s in kidney and pancreas transplant recipients, including lowering blood glucose levels and providing renal protective effects. GLP-1 RAs would be advantageous in liver transplant recipients due to their renal clearance, avoiding interference with immunosuppressant drug metabolism
At the same time, more serious side effects may involve pancreatitis (inflammation of the pancreas), gallbladder issues, and kidney problems
While Remedy Meds may be a fit for some, its worth comparing your options
The peptide is still well within usable range
Retatrutide: Mechanism & Trial Results Retatrutide (LY3437943) is a triple agonist weight loss drug by Eli Lilly